Cencora Cash on Hand 2010-2024 | COR
Cencora cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Cencora cash on hand for the quarter ending June 30, 2024 was $3.306B, a 137.97% increase year-over-year.
- Cencora cash on hand for 2023 was $2.592B, a 23.5% decline from 2022.
- Cencora cash on hand for 2022 was $3.388B, a 33.02% increase from 2021.
- Cencora cash on hand for 2021 was $2.547B, a 44.6% decline from 2020.
| Cencora Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $2,592 |
| 2022 | $3,388 |
| 2021 | $2,547 |
| 2020 | $4,598 |
| 2019 | $3,374 |
| 2018 | $2,493 |
| 2017 | $2,435 |
| 2016 | $2,742 |
| 2015 | $2,167 |
| 2014 | $1,809 |
| 2013 | $1,231 |
| 2012 | $1,067 |
| 2011 | $1,826 |
| 2010 | $1,658 |
| 2009 | $1,009 |
| Cencora Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-06-30 | $3,306 |
| 2024-03-31 | $2,069 |
| 2023-12-31 | $2,872 |
| 2023-09-30 | $2,592 |
| 2023-06-30 | $1,389 |
| 2023-03-31 | $1,539 |
| 2022-12-31 | $1,692 |
| 2022-09-30 | $3,388 |
| 2022-06-30 | $3,034 |
| 2022-03-31 | $2,961 |
| 2021-12-31 | $3,169 |
| 2021-09-30 | $2,547 |
| 2021-06-30 | $2,553 |
| 2021-03-31 | $6,641 |
| 2020-12-31 | $4,891 |
| 2020-09-30 | $4,598 |
| 2020-06-30 | $3,420 |
| 2020-03-31 | $3,692 |
| 2019-12-31 | $3,233 |
| 2019-09-30 | $3,374 |
| 2019-06-30 | $3,000 |
| 2019-03-31 | $2,876 |
| 2018-12-31 | $2,540 |
| 2018-09-30 | $2,493 |
| 2018-06-30 | $2,389 |
| 2018-03-31 | $2,091 |
| 2017-12-31 | $3,038 |
| 2017-09-30 | $2,435 |
| 2017-06-30 | $1,311 |
| 2017-03-31 | $2,404 |
| 2016-12-31 | $1,791 |
| 2016-09-30 | $2,742 |
| 2016-06-30 | $1,865 |
| 2016-03-31 | $2,525 |
| 2015-12-31 | $978 |
| 2015-09-30 | $2,167 |
| 2015-06-30 | $2,555 |
| 2015-03-31 | $2,337 |
| 2014-12-31 | $2,299 |
| 2014-09-30 | $1,809 |
| 2014-06-30 | $1,262 |
| 2014-03-31 | $697 |
| 2013-12-31 | $347 |
| 2013-09-30 | $1,231 |
| 2013-06-30 | $1,568 |
| 2013-03-31 | $1,347 |
| 2012-12-31 | $417 |
| 2012-09-30 | $1,067 |
| 2012-06-30 | $1,656 |
| 2012-03-31 | $2,327 |
| 2011-12-31 | $2,370 |
| 2011-09-30 | $1,826 |
| 2011-06-30 | $2,000 |
| 2011-03-31 | $1,912 |
| 2010-12-31 | $1,401 |
| 2010-09-30 | $1,658 |
| 2010-06-30 | $1,311 |
| 2010-03-31 | $1,200 |
| 2009-12-31 | $980 |
| 2009-09-30 | $1,009 |
| 2009-06-30 | $913 |
| 2009-03-31 | $655 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $46.107B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |